Loading organizations...
Gore Range Capital is a New York City-based venture capital firm that invests in early and growth-stage healthcare businesses, with a specialized focus on skin health innovations. The firm blends private equity expertise with early-stage venture guidance, providing capital and operational, clinical, and scientific support to portfolio companies in areas like dermatology, cancer, and cardiovascular health. Its team collectively boasts over 150 years of healthcare industry experience, with Founding Partner Ethan Rigel having personally invested more than $900 million in companies with a combined enterprise value exceeding $2 billion. Recognizable names associated with the firm include CEO and Founding Partner Ethan Rigel, Partner Humberto Antunes, and advisors Frank DeBernardis, John Friedman, and Ting-Pau Oei. Gore Range Capital was established in 2015 by Ethan Rigel.
Key people at Gore Range Capital.
Key people at Gore Range Capital.
Gore Range Capital has 3 tracked investments across 3 companies. The latest tracked deal is $37.7M Series D in Palvella Therapeutics in January 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 9, 2023 | Palvella Therapeutics | $37.7M Series D | Gore Range Capital, Tadd S. Wessel | Agent Capital, BioAdvance, BVF Partners, Nolan Capital, Samsara BioCapital |
| Nov 14, 2022 | Validic | $12.0M Other Equity | Chris Stenzel | Arkin Digital Health, Green Park & Golf Ventures, Greycroft, SJF Ventures, Ziegler |
| Apr 1, 2020 | Dorsata | $5.0M Series A | — | 1776, Tide Africa Fund, Labcorp, Motley Fool Ventures, QED Investors, Women |
